PPTA Twitter

PlasmaProteins Johan Prevot, Executive Director of @ipopi_info , is a leading global voice for patient access to #PPTs . @PlasmaProteins is proud to work with him and his partner organizations to ensure those who need these therapies can receive them. Read more: bit.ly/30xcxQz pic.twitter.com/BOF4y5uVTj
About 13 hours ago.
PlasmaProteins . @PlasmaProteins & @HIYDglobal every patient’s story helps us #AdvocateForPPTs . Tell us your story at share.howisyourday.org pic.twitter.com/jVmgvMKHtE
5 days ago.

PPTA Presents in Malta

During the biannual Plasma Product Biotechnology Meeting held 15-19 May in Malta, PPTA was invited to make two presentations:

"The World Needs Plasma from the USA and Other Countries" described the importance of U.S. plasma for the manufacturing of plasma protein therapies in the world, the need to remove restrictions on Source plasma collections in other countries and a better use of recovered plasma to meet patient needs.

"Source Plasma Safety" addressed the various steps in donor screening and the value of Source Industry standards for Qualified donors, Inventory hold, and viral marker rates. Residual risk of a window period donation entering the manufacturing pool was discussed. as well as the effectiveness of viral inactivation/ removal were also presented.

Both presentations are available on our website.

Copyright © 2020 PPTA. All rights reserved. (202) 789-3100